Hypertensive emergencies

Critical Care Clinics

Volumn 17, Issue 2, 2001, Pages 435-451

  Elliott, William J ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; FENOLDOPAM; GLYCERYL TRINITRATE; HYDRALAZINE; MAGNESIUM SULFATE; METHYLDOPA; NIMODIPINE; NITROPRUSSIDE SODIUM; PHENTOLAMINE;

ACUTE HEART INFARCTION; AORTA DISSECTING ANEURYSM; BLOOD PRESSURE; CATECHOLAMINE RELEASE; CLINICAL FEATURE; DISEASE PREDISPOSITION; HYPERTENSION; INTENSIVE CARE; LUNG EDEMA; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0034959036     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(05)70176-7     Document Type: Article

References (45)

1. Lack of difference between malignant and accelerated hypertension
2. Transient and sustained recovery from renal shutdown in accelerated hypertension
3. Blood pressure and functional recovery in acute ischemic stroke
4. Managing hypertensive urgencies in primary care
5. Aortic dissection
6. Malignant hypertension
7. Hypertensive crises
8. Hypertensive emergencies and aortic dissection
9. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: A systematic review
10. Management of hypertensive crises
11. Comparative tolerability profile of hypertensive crisis treatments
12. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
13. Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises
14. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies
15. Course of blood pressure within the first 12 hours of hypertensive urgencies
16. Hemodynamic cerebral infarction triggered by excessive blood pressure reduction in hypertensive emergencies
17. Pathophysiology, clinical aspects, and treatment of hypertensive crises
18. Recovery in malignant hypertension presenting as acute renal failure
19. The hypertensive "breakthrough" of autoregulation of cerebral blood flow with forced vasodilation, flow increase, and blood-brain barrier damage
20. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
21. Management of hypertensive emergencies
22. Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension
23. Malignant hypertension and hypertensive emergencies
24. Malignant hypertension in young women is related to previous hypertension in pregnancy, not oral contraception
25. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials
26. Nifedipine and arotinolol in combination for accelerated-malignant hypertension: Results of one year follow-up
27. Malignant hypertension in a patient with primary hyperaldosteronism with elevated active renin concentration
28. Malignant hypertension in women 15-44 years, and its relation to cigarette smoking and oral contraceptives
29. Fenoldopam: A new dopamine agonist for the treatment of hypertensive urgencies and emergencies
30. Parenteral hydralazine revisited
31. A comparison of antihypertensive efficacy and safety of felodipine IV and nifedipine IV in patients with hypertensive crisis or emergency not responding to oral nifedipine
32. Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies
33. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies
34. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population
35. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with normal or impaired baseline renal function
36. Dissection of the aorta
37. Tratamiento de la urgencia hipertensiva con licidipino
38. Is there a difference in hypertensive claim rates among Medicaid recipients?
39. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy
40. Intravenous nicardipine in the treatment of postoperative arterial hypertension
41. Diagnostic and therapeutic procedures by doctors for patients in a hypertensive crisis: An inquiry in 56 internal medicine clinics
42. The FDA's decisions regarding new indications for approved drugs. Where's the evidence?
43. Cardiovascular toxicity after ingestion of "herbal ecstacy."
44. Malignant hypertension in association with primary hyperaldosteronism
45. Rapid reduction of severe asymptomatic hypertension: A prospective controlled trial